LOC643923: A Protein of Interest for Drug Development (G643923)
LOC643923: A Protein of Interest for Drug Development
LOC643923 is a protein that is expressed in various tissues of the body, including the brain, heart, liver, and kidneys. It is a member of the heat shock protein (HSP) family, which are proteins that are expressed in high abundance in response to increased levels of thermal stress.
LOC643923 is unique because it has a unique structure that allows it to interact with small molecules, such as drugs, toxins, and other substances that are present in the body. This interaction allows LOC643923 to play a role in a wide range of biological processes, including the regulation of cellular signaling pathways, the development and progression of diseases, and the regulation of cellular processes that are critical for human health.
One of the ways that LOC643923 is involved in cellular signaling pathways is through its role in the regulation of the protein kinase PDK4. PDK4 is a enzyme that is involved in the regulation of many cellular processes, including cell growth, differentiation, and survival. LOC643923 has been shown to interact with PDK4 and to play a role in the regulation of its activity.
In addition to its role in PDK4 regulation, LOC643923 is also involved in the regulation of a protein called TDP-4. TDP-4 is a protein that is involved in the regulation of the stress response, and is expressed in high abundance in response to increased levels of stress. LOC643923 has been shown to interact with TDP-4 and to play a role in the regulation of its activity.
LOC643923 is also involved in the regulation of the cytoskeleton, which is the structure that gives cells their shape and supports their mechanical properties. The cytoskeleton is involved in many cellular processes, including cell division, migration, and the regulation of cell-cell interactions. LOC643923 has been shown to interact with the protein F-actinin, which is involved in the regulation of the cytoskeleton.
In addition to its role in cytoskeleton regulation, LOC643923 is also involved in the regulation of many other cellular processes. For example, it is involved in the regulation of cell adhesion, cell signaling pathways, and the regulation of DNA replication.
LOC643923 is also of interest because it has been shown to play a role in the development and progression of certain diseases, including cancer. For example, LOC643923 has been shown to be involved in the regulation of the angiogenesis that occurs in the development of cancer. In addition, LOC643923 has also been shown to play a role in the regulation of the immune response, which is important for the regulation of cancer growth and the rejection of foreign tumors.
LOC643923 is also of interest because it has been shown to have potential as a drug target. The ability of LOC643923 to interact with small molecules and to play a role in the regulation of cellular signaling pathways makes it an attractive target for drug development. Additionally, LOC643923's unique structure and its involvement in a wide range of cellular processes make it an attractive target for drug development.
In conclusion, LOC643923 is a protein that is expressed in various tissues of the body and is involved in a wide range of cellular processes. Its unique structure and its involvement in the regulation of cellular signaling pathways, the development and progression of diseases, and the regulation of cellular processes that are critical for human health make it an attractive target for drug development. Further research is needed to fully understand the role of LOC643923 in cellular processes and its potential as a drug target.
Protein Name: Uncharacterized LOC643923
The "LOC643923 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC643923 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
LOC644006 | LOC644083 | LOC644086 | LOC644189 | LOC644215 | LOC644277 | LOC644525 | LOC644584 | LOC644634 | LOC644656 | LOC644662 | LOC644669 | LOC644893 | LOC644936 | LOC645086 | LOC645181 | LOC645188 | LOC645266 | LOC645468 | LOC645503 | LOC645967 | LOC646044 | LOC646214 | LOC646358 | LOC646471 | LOC646674 | LOC646736 | LOC646762 | LOC646813 | LOC646836 | LOC646853 | LOC646903 | LOC646934 | LOC646970 | LOC647115 | LOC647132 | LOC647481 | LOC649133 | LOC650157 | LOC650226 | LOC651536 | LOC652276 | LOC652608 | LOC653303 | LOC653503 | LOC653513 | LOC653631 | LOC653653 | LOC653698 | LOC727751 | LOC728024 | LOC728098 | LOC728114 | LOC728138 | LOC728376 | LOC728392 | LOC728417 | LOC728485 | LOC728554 | LOC728660 | LOC728688 | LOC728715 | LOC728739 | LOC728743 | LOC728877 | LOC728989 | LOC729086 | LOC729164 | LOC729173 | LOC729218 | LOC729296 | LOC729444 | LOC729609 | LOC729683 | LOC729732 | LOC729737 | LOC729815 | LOC729870 | LOC729887 | LOC729966 | LOC729973 | LOC730098 | LOC730100 | LOC730101 | LOC730183 | LOC730234 | LOC730338 | LOC730668 | LOC90246 | LOC91450 | LOC93429 | LOC93463 | LOC93622 | LOH12CR2 | Long intergenic non-protein coding RNA 1336 | Long intergenic non-protein coding RNA 205 | Long intergenic non-protein coding RNA 266-4, pseudogene | Long-chain-fatty-acid--CoA ligase | LONP1 | LONP2
